ATE147936T1 - Verfahren und zusammensetzungen für die behandlung durch t-zellen vermittelter krankheiten - Google Patents

Verfahren und zusammensetzungen für die behandlung durch t-zellen vermittelter krankheiten

Info

Publication number
ATE147936T1
ATE147936T1 AT91916302T AT91916302T ATE147936T1 AT E147936 T1 ATE147936 T1 AT E147936T1 AT 91916302 T AT91916302 T AT 91916302T AT 91916302 T AT91916302 T AT 91916302T AT E147936 T1 ATE147936 T1 AT E147936T1
Authority
AT
Austria
Prior art keywords
methods
compositions
treating
mediated diseases
cell mediated
Prior art date
Application number
AT91916302T
Other languages
English (en)
Inventor
Daniel Meruelo
Gad Lavie
Original Assignee
Univ New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York filed Critical Univ New York
Application granted granted Critical
Publication of ATE147936T1 publication Critical patent/ATE147936T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT91916302T 1990-08-23 1991-08-23 Verfahren und zusammensetzungen für die behandlung durch t-zellen vermittelter krankheiten ATE147936T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57208590A 1990-08-23 1990-08-23

Publications (1)

Publication Number Publication Date
ATE147936T1 true ATE147936T1 (de) 1997-02-15

Family

ID=24286285

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91916302T ATE147936T1 (de) 1990-08-23 1991-08-23 Verfahren und zusammensetzungen für die behandlung durch t-zellen vermittelter krankheiten

Country Status (4)

Country Link
EP (1) EP0544802B1 (de)
AT (1) ATE147936T1 (de)
DE (1) DE69124380T2 (de)
WO (1) WO1992003049A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319914B1 (en) 1993-11-05 2001-11-20 Apollo Biopharmaceuticals, Inc. Cytoprotective effect of polycyclic phenolic compounds
US5859001A (en) * 1996-01-11 1999-01-12 University Of Florida Research Foundation, Inc. Neuroprotective effects of polycyclic phenolic compounds
US6197833B1 (en) 1995-07-24 2001-03-06 Apollo Biopharmaceutics, Inc. Neuroprotective effects of polycyclic phenolic compounds
US6089456A (en) * 1995-06-07 2000-07-18 E-Comm Incorporated Low power telecommunication controller for a host computer server
WO1996041447A1 (en) * 1995-06-07 1996-12-19 E-Comm Incorporated Low power telecommunication controller for a host computer server
EP0841906A1 (de) * 1995-07-24 1998-05-20 University Of Florida Research Foundation, Inc. Verwendung nicht-östrogener polycylischer phenolverbindungen zur herstellung eines arzneimittels zur bewirkung einer neuroprotektion von zellen
US6864232B1 (en) 1998-12-24 2005-03-08 Sucampo Ag Agent for treating visual cell function disorder
WO2000038703A1 (en) * 1998-12-24 2000-07-06 R-Tech Ueno, Ltd. Agent for treating visual cell function disorder

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4705687A (en) * 1985-06-17 1987-11-10 Ortho Pharmaceutical (Canada) Ltd. Treatment of autoimmune diseases such as rheumatoid arthritis with suppressor factor
FR2586349B1 (fr) * 1985-08-22 1988-07-01 Roussel Uclaf Utilisation de derives de l'acide maleopimarique pour l'obtention d'un medicament immunomodulateur
WO1989001329A1 (en) * 1987-08-10 1989-02-23 New York University Antiviral compositions containing aromatic polycyclic diones and method for treating retrovirus infections
US4989891A (en) * 1990-04-12 1991-02-05 Huang Ming Tai Removable safety bar for a baby stroller

Also Published As

Publication number Publication date
WO1992003049A1 (en) 1992-03-05
DE69124380D1 (de) 1997-03-06
EP0544802A4 (en) 1993-08-04
EP0544802B1 (de) 1997-01-22
EP0544802A1 (de) 1993-06-09
DE69124380T2 (de) 1997-08-14

Similar Documents

Publication Publication Date Title
YU46097A (sh) Nova klasa estara i njihove farmaceutske smeše
IL94990A0 (en) Pharmaceutical compositions for the prophylaxis and/or treatment of prostatic diseases
TR199903331T2 (xx) Farnesil protein transferas engelleyicileri.
ATE98867T1 (de) Poroese einheitsform und verfahren.
NO20050807L (no) Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser
KR910000169A (ko) 포유류에서 이식 거부를 억제시키는 라파마이신의 용도
OA07116A (fr) Esters aromatiques hétérocycliques de stéroïdes, leur préparation et compositions pharmaceutiques les contenant.
DE69027865D1 (de) ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN
BR9106438A (pt) Composicoes terapeuticas sinergisticas e processos
ATE209908T1 (de) RADIKALFÄNGER (ßSPIN TRAPSß) ZUR BEHANDLUNG VON MIT OXIDATION VON LIPIDEN UND PROTEINEN VERBUNDENEN ERKRANKUNGEN
ATE411026T1 (de) Mittel zur behandlung der alzheimer-krankheit
GEP20033081B (en) Pharmaceutical Agents for Treatment of Parkinson's Disease, ADFD and Microadenomas
ATE199167T1 (de) Nichtglykosyliertes fgf-4 und dieses enthaltende präparate
DE69429806D1 (de) Pharmazeutische zusammensetzungen zur prävention und behandlung von krebserkrankungen und verfahren für ihre herstellung
PA8457001A1 (es) Derivados del 2-(4-aril o heteroaril-piperazin-i-ilmetil)-1h-indol
DE69124380D1 (de) Verfahren und zusammensetzungen für die behandlung durch t-zellen vermittelter krankheiten
ATE313324T1 (de) Verwendung von brefeldin a und deren derivate in der herstellung von arzneimittel zur behandlung von hyperplasie und verwandten erkrankungen
ZA886097B (en) Pharmaceutical composition for the treatment of psoriasis
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
ATE489T1 (de) Sila-substituierte 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung, arzneimittel und verfahren zu deren herstellung.
MX9702926A (es) L-eritrosilnucleosidos.
FI954245A7 (fi) Koostumuksia ja menetelmiä immunovälitteisten tulehduksellisten häiriö iden hoitamiseksi
FR2612775B1 (fr) Compositions pour la prevention et le traitement de la degenerescence cutanee
GR3019121T3 (en) Pyridylphenyl nitrogen heterocycle-substituted carbinols and derivatives thereof with anti-inflammatory activity
DE59010302D1 (de) R-(-)-1-(5-Hydroxyhexyl)-3-methyl-7-propylxanthin, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties